Sentara Heart’s Annual PAH Symposium offers a comprehensive survey of current knowledge in the field of pulmonary hypertension. The sessions will increase attendee knowledge about diagnosis and management of this complex disease. Attendees will be better equipped to detect pulmonary hypertension in at risk populations and begin early treatment.
The symposium will be of value to physicians and advanced practice providers in pulmonary medicine, critical care medicine, as well as internal medicine & family medicine. It will likewise be valuable to allied health professionals and advanced practice physician trainees who wish to explore pulmonary vascular disease.

TARGETED AUDIENCE

Specialties - Critical Care Medicine, Internal Medicine, PCCM, Pulmonary Disease
Professions - Allied Health Professional, Fellow, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician Assistant, Resident, Student

LEARNING OBJECTIVES

At the conclusion of this activity, learners will be able to:

• Identify signs, symptoms, and risk factors associated with PAH to facilitate timely referral of patients.
• Articulate diagnostic tests used to identify patients with PAH.
• Design a more rapid and multidisciplinary approach to earlier detection of PAH.
• Appraise future advancements of care in pulmonary hypertension.
• Describe the pharmacologic management of PAH patients.

ACCREDITATION

Sentara is accredited by the Medical Society of Virginia (MSV) to provide continuing medical education for physicians.
Sentara designates this Live Activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.